MiNK Therapeutics, Inc.INKTNASDAQ
Loading
Net Debt Over TimeCompressed
Percentile Rank60
5Y CAGR-58.0%
Studio
Year-over-Year Change

Total debt minus cash and cash equivalents

5Y CAGR
-58.0%/yr
Long-term compound
Percentile
P60
Within normal range
vs 5Y Ago
0x
Contraction
Streak
3 yr
Consecutive growthCompressed
PeriodValueYoY Change
2024$347572.00+110.3%
2023$-3.37M+82.9%
2022$-19.64M+49.5%
2021$-38.89M-194.5%
2020$41.13M+55.3%
2019$26.49M-